TipRanks
Go Ultimate55% OFF

Collegium Pharmaceutical (COLL) Q4 2018 Earnings Report

513 Followers

COLL Q4 2018 EPS Results

Actual EPS
-$0.10
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-$0.54

COLL Q4 2018 Revenue Results

Actual Revenue
$73.43M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q4 2018
Date
02/27/2019
Time
TBA
Conference Call
Wednesday, February 27, 2019
COLL Upcoming Earnings

Collegium Pharmaceutical's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

Q4 2018 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2018 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2018 Earnings Call Summary

No earnings call summary is available for this earnings event.

COLL Earnings History

COLL earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 05, 20262026 (Q3)1.86-2.25――
Aug 06, 20262026 (Q2)1.721.921.6814.29% (+0.24)
May 07, 20262026 (Q1)1.521.761.4918.12% (+0.27)
Feb 26, 20262025 (Q4)2.142.041.7715.25% (+0.27)
Nov 06, 20252025 (Q3)1.862.251.6139.75% (+0.64)
Aug 07, 20252025 (Q2)1.621.681.623.70% (+0.06)
May 08, 20252025 (Q1)1.431.491.452.76% (+0.04)
Feb 27, 20252024 (Q4)1.541.771.5812.03% (+0.19)
Nov 07, 20242024 (Q3)1.591.611.3420.15% (+0.27)
Aug 08, 20242024 (Q2)1.491.621.2628.57% (+0.36)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed